2,084 reports of this reaction
3.6% of all CINACALCET HYDROCHLORIDE reports
#6 most reported adverse reaction
INTENTIONAL PRODUCT MISUSE is the #6 most commonly reported adverse reaction for CINACALCET HYDROCHLORIDE, manufactured by Amgen Inc. There are 2,084 FDA adverse event reports linking CINACALCET HYDROCHLORIDE to INTENTIONAL PRODUCT MISUSE. This represents approximately 3.6% of all 57,261 adverse event reports for this drug.
Patients taking CINACALCET HYDROCHLORIDE who experience intentional product misuse should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
INTENTIONAL PRODUCT MISUSE is moderately reported among CINACALCET HYDROCHLORIDE users, representing a notable but not dominant share of adverse events.
In addition to intentional product misuse, the following adverse reactions have been reported for CINACALCET HYDROCHLORIDE:
The following drugs have also been linked to intentional product misuse in FDA adverse event reports:
INTENTIONAL PRODUCT MISUSE has been reported as an adverse event in 2,084 FDA reports for CINACALCET HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
INTENTIONAL PRODUCT MISUSE accounts for approximately 3.6% of all adverse event reports for CINACALCET HYDROCHLORIDE, making it a notable side effect.
If you experience intentional product misuse while taking CINACALCET HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.